Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
AM

Arvind Mathur — 10 Patents

IIIsp Investments: 4 patents #99 of 418Top 25%
Bristol-Myers Squibb: 4 patents #1,199 of 3,969Top 35%
MUMichigan State University: 2 patents #19 of 212Top 9%
Bound Brook Junction, NJ: #57 of 213 inventorsTop 30%
New Jersey: #8,961 of 69,400 inventorsTop 15%
Overall (All Time): #481,000 of 4,157,543Top 15%
10 Patents All Time
Arvind Mathur has been granted 10 US patents while listed as an inventor at Isp Investments. The first was granted in 1996 and the most recent in June 2025. Arvind Mathur ranks #481,000 of 4,157,543 US inventors in our database (top 11.6%). Patent records list Arvind Mathur in Bound Brook Junction, NJ, US.

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12331045 Substituted phenyl oxazolone compounds Lan-Ying Qin, Zheming Ruan, Ashok Vinayak Purandare, Emily Charlotte Cherney, James Aaron Balog +1 more 2025-06-17
7145040 Process for the preparation of amino acids useful in the preparation of peptide receptor modulators K. Selva Kumar 2006-12-05 $42,504,000
6417356 Stabilization of vinylether and vinyl lactam formulations against hydrolysis James A. Dougherty 2002-07-09
6359128 Free-flowing flakes of vinyl caprolactam monomer and process for making same James A. Dougherty, Philip F. Wolf 2002-03-19
6174933 Radiation polymerizable vinylether-based compositions James A. Dougherty, John Mckittrick 2001-01-16
6063864 Curable, unsaturated polyester compositions James A. Dougherty 2000-05-16
5844039 Polymers comprising reversible hydrophobic functionalities Alec B. Scranton, John Klier 1998-12-01
5776983 Catecholamine surrogates useful as .beta..sub.3 agonists William N. Washburn, Ravindar N. Girotra, Philip M. Sher, Amarendra B. Mikkilineni, Kathleen M. Poss +2 more 1998-07-07 $157,739,000
5739210 Polymers comprising reversible hydrophobic functionalities Alec B. Scranton, John Klier 1998-04-14
5491134 Sulfonic, phosphonic or phosphiniic acid .beta..sub.3 agonist derivatives Philip M. Sher 1996-02-13 $169,141,000